-
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
06 May 2025 12:30 GMT
… "Company"), a biotechnology company developing leronlimab, a … in a number of biotech executive and board roles. … Hoffman started his career at Arena Pharmaceuticals, Inc., rising through the … is a clinical-stage biotechnology company focused on the …
-
Crohn's Disease Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
10 Jul 2025 03:19 GMT
… Biopharma, TaiwanJ Pharmaceuticals, Active Biotech, Celularity, Cerecor, GlaxoSmithKline, … , Innovimmune Biotherapeutics, JHL Biotech, Intract Pharma Ltd, Innovative … , Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, Priothera, and others …
-
Crohn's Disease Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Anssen, Redhill Biopharma, Amgen, Pfizer, Prometheus Biosciences, Agomab Therape
09 Jul 2025 01:44 GMT
… , Abivax, Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem Inc., Stero Biotechs, Reistone …
-
Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals
02 Jul 2024 17:00 GMT
… Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals, BioMimetix, Eli Lilly and … Pharmaceutical Industries Limited, Brickell Biotech Inc, Dermira, AstraZeneca, Kyowa … Limited, JW Pharmaceutical, Oneness Biotech, Alphyn Biologics, selectION, UNION …
-
Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, T
02 May 2024 17:00 GMT
… Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem Inc., Stero Biotechs, … bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, NGM Biopharmaceuticals … bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, OrphoMed, …
-
How Cannabinoid Biotechs Are Potentially Enhancing Long-Term Stock Performance
13 Aug 2024 20:23 GMT
… revenue opportunities.
Of course, biotech stocks, including those of companies … Practices (GMP).
Investing in biotechs developing medicinal cannabinoid products
Nonetheless … acquire clinical-stage cannabinoid firm Arena Pharmaceuticals in 2021.
Exchange-traded …
-
North America Legal Cannabis Market Report 2022: Featuring 22nd Century, Medical Marijuana Inc, Arena Pharmaceuticals & More - ResearchAndMarkets.com
20 Jan 2023 16:42 GMT
…
Medical Marijuana Inc
HempInc
Axim Biotechnologies
Arena Pharmaceuticals Inc
Canopy Growth Corporation
Aphria …
-
Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com
13 Mar 2024 13:11 GMT
… Therapeutics
Arcus Biosciences
Ardelyx
Arena Pharmaceuticals
Arrowhead Pharmaceuticals
Artiva …
BioProspect
Biostem US
Biotech Investment
Biotechnology Value Fund
BioTime … Therapeutics
Omeros
Oncologie
Oncolytics Biotech
OncoMed Pharmaceuticals
Onconova …
-
Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer
16 Oct 2023 11:28 GMT
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Manmeet S. Soni has been appointed as the Company’s Chief Operating Officer, effective immediately. Mr. Soni will remain a member of the Company’s Board of …
-
Pfizer intends to purchase Arena Pharmaceuticals for USD6.7B
14 Dec 2021 10:46 GMT
… via COMTEX) --
(MENAFN) US biotechnology company Pfizer stated that it … purchase California-based pharmaceutical firm Arena Pharmaceuticals for USD6.7 billion, and …
About
© 1995-2025